Cetuximab pharmacokinetics influences progression-free survival of metastatic colorectal cancer patients. [electronic resource]
Producer: 20120127Description: 6329-37 p. digitalISSN:- 1557-3265
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Cetuximab
- Colorectal Neoplasms -- drug therapy
- Disease-Free Survival
- Drug Administration Schedule
- Female
- Fluorouracil -- administration & dosage
- Humans
- Male
- Middle Aged
- Neoplasm Metastasis
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.